497 related articles for article (PubMed ID: 16550633)
1. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
Bamba S; Lee CY; Brittan M; Preston SL; Direkze NC; Poulsom R; Alison MR; Wright NA; Otto WR
J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts.
Andoh A; Zhang Z; Inatomi O; Fujino S; Deguchi Y; Araki Y; Tsujikawa T; Kitoh K; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y
Gastroenterology; 2005 Sep; 129(3):969-84. PubMed ID: 16143135
[TBL] [Abstract][Full Text] [Related]
3. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N
Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
5. Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease.
Andoh A; Shioya M; Nishida A; Bamba S; Tsujikawa T; Kim-Mitsuyama S; Fujiyama Y
J Immunol; 2009 Jul; 183(1):687-95. PubMed ID: 19535621
[TBL] [Abstract][Full Text] [Related]
6. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
[TBL] [Abstract][Full Text] [Related]
7. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
Shioya M; Nishida A; Yagi Y; Ogawa A; Tsujikawa T; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y; Andoh A
Clin Exp Immunol; 2007 Sep; 149(3):480-6. PubMed ID: 17590175
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase from bone marrow-derived cells plays a critical role in regulating colonic inflammation.
Beck PL; Li Y; Wong J; Chen CW; Keenan CM; Sharkey KA; McCafferty DM
Gastroenterology; 2007 May; 132(5):1778-90. PubMed ID: 17449036
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
Nakase H; Okazaki K; Tabata Y; Chiba T
J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
[TBL] [Abstract][Full Text] [Related]
10. Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR.
Nguyen Van N; Taglinger K; Helps CR; Tasker S; Gruffydd-Jones TJ; Day MJ
Vet Immunol Immunopathol; 2006 Oct; 113(3-4):404-14. PubMed ID: 16879876
[TBL] [Abstract][Full Text] [Related]
11. Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells.
Matsumoto S; Nagaoka M; Hara T; Kimura-Takagi I; Mistuyama K; Ueyama S
Clin Exp Immunol; 2004 Jun; 136(3):432-9. PubMed ID: 15147344
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation.
Shkoda A; Ruiz PA; Daniel H; Kim SC; Rogler G; Sartor RB; Haller D
Gastroenterology; 2007 Jan; 132(1):190-207. PubMed ID: 17241871
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.
Sato T; Nakai T; Tamura N; Okamoto S; Matsuoka K; Sakuraba A; Fukushima T; Uede T; Hibi T
Gut; 2005 Sep; 54(9):1254-62. PubMed ID: 16099792
[TBL] [Abstract][Full Text] [Related]
14. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
15. Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease.
Bhavsar MD; Amiji MM
Gene Ther; 2008 Sep; 15(17):1200-9. PubMed ID: 18418416
[TBL] [Abstract][Full Text] [Related]
16. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases.
Shoda H; Fujio K; Yamaguchi Y; Okamoto A; Sawada T; Kochi Y; Yamamoto K
Arthritis Res Ther; 2006; 8(6):R166. PubMed ID: 17078892
[TBL] [Abstract][Full Text] [Related]
17. Study of cytokines in ulcerative colitis.
Funakoshi K; Sugimura K; Sasakawa T; Bannai H; Anezaki K; Ishizuka K; Yoshida K; Narisawa R; Asakura H
J Gastroenterol; 1995 Nov; 30 Suppl 8():61-3. PubMed ID: 8563893
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.
Mazzucchelli L; Hauser C; Zgraggen K; Wagner H; Hess M; Laissue JA; Mueller C
Am J Pathol; 1994 May; 144(5):997-1007. PubMed ID: 8178948
[TBL] [Abstract][Full Text] [Related]
19. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry.
ter Beek WP; Biemond I; Muller ES; van den Berg M; Lamers CB
Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
